<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824607/" ref="ordinalpos=3116&amp;ncbi_uid=6435200&amp;link_uid=PMC3824607" image-link="/pmc/articles/PMC3824607/figure/F3/" class="imagepopup">Fig.3.  From: TNFR1 <span class="highlight" style="background-color:">Signaling</span> Kinetics: Spatiotemporal Control of Three Phases of IKK activation by Posttranslational Modification. </a></div><br /><div class="p4l_captionBody">Crosstalk in TNFR1 signaling. Ligation of TNFR1 leads to activation of the pro-inflammatory NF-κB and JNK, and pro-apoptotic caspase-8 and ROS pathways. However, in normal cells, NF-κB target gene products suppress pro-apoptotic pathways. For instance, cIAP1/2 and cFLIP inhibit caspase-8 activation, XIAP and GADD45β suppress prolonged JNK activation, and FHC and Mn-SOD inhibit ROS accumulation. Therefore, unless NF-κB pathway is blocked, TNFα is insufficient to induce cell death.</div></div>